Explore Latest News

Genitourinary Cancers (GU)

"A Potential Huge Benefit For Patients"--PIVOT-006 and the Future of Intermediate-Risk NMIBC

Genitourinary Cancers (GU)

A Watershed Moment In Bladder Cancer Care, According To Leading Oncologists: The IMvigor011 Study and the Rise of ctDNA-Guided Treatment

Genitourinary Cancers (GU)

Case Western's Dr. Jorge Garcia On Practical Use of ctDNA To Make Better Treatment Decisions For Bladder Cancer Patients

Multiple Myeloma

NYU Langone's Dr. Marc Braunstein On Decision-Making In The New Era of Multiple Myeloma Treatment

Lung Cancer

"Striking," "Practice Changing" & Way "More Study Needed"- Oncologists Debate The New Data On Time of Day As a Predictor of Check Point Inhibitor Efficacy

Genitourinary Cancers (GU)

Perioperative EV + Pembrolizumab For MIBC: The New Standard of Care, According to Leading Bladder Cancer Experts

Genitourinary Cancers (GU)

Intravesical Mitomycin Gel: A New Approach For Recurrent NMIBC

Follicular Lymphoma

NYU's Dr. Catherine Diefenbach On Navigating the Evolving Chemo-Free Landscape in Relapsed Follicular Lymphoma

Dr. Natalie Rafaeli

Follicular Lymphoma

Breast Oncologist Dr. Kevin Punie on Why Sacituzumab Govitecan Belongs in First Line MBC Treatment